These multi-bagging FTSE 250 growth stocks could still make you rich

These two stocks are up more than 200% in five years and could have further to go, says Harvey Jones.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Everybody loves a multi-bagger. Here are two FTSE 250 stocks that have turned on the charm in recent years, but whose unglamorous nature makes them all too easy to overlook.

Animal spirits

FTSE 250 meat supplier Cranswick (LSE: CWK) has shown plenty of beef lately, its share price rising a meaty 245% over the past five years. It is up another 16% in the last six months, suggesting the growth story has yet to run its course. The company continues to report strong financial and strategic progress, with full-year revenues up 22.5% to £1.25bn, or 12.7% on a like-for-like basis, and adjusted profit before tax up 17.2% to £75.5m.

Management increase the recommended final dividend by 19.7% to 31p, with overall performance turbo-charged by further strong progress in key export markets, notably Asia, where revenues leapt 49%. Although net debt did increase last year, by £28.8m to £11m, this was cash wisely spent on corporate transactions and investment in its asset base, exactly what you want expect an expanding company to do.

Plenty of juice

Despite record capital expenditure of £47m to support its strong growth pipeline, Cranswick’s net debt totals just 2.6% of shareholders’ funds. Nothing to worry about here. It may describe itself as a conservatively managed company but there is nothing conservative about the rate of its share price growth. Three years of double-digit earnings per share (EPS) growth looks set to continue in 2018 with 12% pencilled-in, although dipping to 5% in 2019. Revenues and pre-tax profits are expected to continue rising, albeit at a slightly slower pace.

Cranswick now trades at a forecast 20.9 times earnings, so there is a price to pay for its growth prospects. Its price-to-earnings growth (PEG) ratio is 1.3, again, suggesting this stock is trading at a premium. The forecast yield of 1.8% is relatively low but covered 2.8 times so there is plenty of scope for further progression, and management certainly hasn’t disappointed on that front lately. There is still plenty for investors to sink their teeth into, although the share price may struggle to match recent stellar growth.

Strong growth

Funeral specialist Dignity (LSE: DTY) has also enjoyed a successful five years, its share price up 210% in that time, even if the last couple of years have been disappointingly flat. That is despite management recently reporting a 15% jump in Q1 revenues to £93.3m and restating that the company is set to meet its full-year expectations, as the number of deaths rose from 156,000 to 167,000.

Dying is a growing business, I guess, although you have to balance rapid increases in the UK population against increases in longevity. The group said it continues to assume that the number of deaths this year will be lower than in 2016, which may partly account for lower investor expectations.

Dignity has a successful pre-arranged funeral plan business, with sales rising significantly, and is steadily acquiring more funeral locations. Like Cranswick, share price success has led to a pricey valuation, currently 20 times earnings, although this is in line with recent years. Double-digit EPS growth, which hit a whopping 34% in 2015, looks set to slow to single-digits. The growth story should continue, but again, probably at a slightly slower pace.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Harvey Jones has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »